Diagnosis

Home » Diagnosis

Men (aged 40-49 years) with a single baseline PSA below 1.0 have a very low long-term risk of prostate cancer

Diagnosis / By / / 2 minutes of reading

Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: Results from a prospectively screened population cohort – Abstract [www.urotoday.com] Published on 19 November 2013 OBJECTIVE: To study the use of a baseline prostate-specific antigen (PSA) and digital rectal examination in men (aged 40-49 years) in predicting long-term prostate cancer risk in a prospectively followed, representative population cohort. PATIENTS AND METHODS: Since 1990, a random sample of men in Olmsted County (aged 40-49 years) has been followed up prospectively (n = 268), with biennial visits, including a urologic […]

Men (aged 40-49 years) with a single baseline PSA below 1.0 have a very low long-term risk of prostate cancer Read More »

New prostate test that identifies less harmful tumours that do not need to be removed immediately will spare men from needless surgery

Active Surveillance, Diagnosis / By / / 1 minute of reading

A new test for prostate cancer could spare thousands of men needless treatment which leaves them with debilitating side effects, researchers claim. The test can accurately pinpoint the less harmful tumours which do not have to be immediately removed by surgery or radiotherapy. Read more: http://www.dailymail.co.uk/health/article-2487483/New-prostate-test-identifies-harmful-tumours-need-removed-immediately-spare-men-needless-surgery.html#ixzz2lIfSTsd7

New prostate test that identifies less harmful tumours that do not need to be removed immediately will spare men from needless surgery Read More »

VIDEO: Dr. Danny Vesprini, “Prostate Cancer – identifying men at high risk before it’s too late”

Videos, Awareness Nights, Diagnosis / By / / 1 minute of reading

September 2013 Scotiabank Awareness Night “Prostate Cancer – identifying men at high risk before it’s too late” Dr. Danny Vesprini,   MD, MSc, BSc, FRCPC Assistant Professor  Department of Radiation Oncology, University of Toronto  Staff Radiation Oncologist, Sunnybrook Odette Cancer Centre Dr. Vesprini discusses the current and upcoming strategies for screening and ultimately treating men who are at increased risk of developing aggressive prostate cancer, including men with a strong family history, men with a known genetic trait that causes aggressive disease, and men of Western African/Caribbean descent. CLICK ON THE ARROW TO START THE VIDEO Click here for Complete Video  Introduction by

VIDEO: Dr. Danny Vesprini, “Prostate Cancer – identifying men at high risk before it’s too late” Read More »

New Urine Test for Prostate Cancer – More Specific

Diagnosis / By / / 1 minute of reading

Prostate Cancer Foundation Announces New Urine Test for Prostate Cancer Available; Unlike PSA Test, is Ultra Specific for Prostate Cancer A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs. The new test—Mi-Prostate Score (MiPS)—improves the utility of the PSA blood test, increases physicians’ ability to pick out high-risk prostate tumors from low-risk tumors in patients, and may help tens of thousands of men avoid unnecessary biopsies. Read the article.

New Urine Test for Prostate Cancer – More Specific Read More »

PCC Releases New Recommmendations on PSA Testing

News, Diagnosis / By / / 1 minute of reading

Sept. 5, 2013 PROSTATE CANCER CANADA RELEASES NEW RECOMMENDATIONS Lowering the age of baseline testing for prostate cancer Today we released new recommendations to empower Canadian males to take a more active role in monitoring their number one cancer risk: prostate cancer. A recent nationwide poll showed that while 87% of Canadian men aged 35+ fear prostate cancer, less than half anticipate being tested in the next 12 months – even though early diagnosis can increase the odds of survival. Read about it.

PCC Releases New Recommmendations on PSA Testing Read More »

5 Ways to Prevent Unnecessary Treatment for Prostate Cancer

Active Surveillance, Diagnosis / By / / 1 minute of reading

Now that the government panels and medical associations no longer recommend PSA testing, consider this: in the 1980s, before PSA testing, 50,000 men died annually from prostate cancer. In the 1990s, with PSA testing, 30,000 died annually. PSA testing saved 20,000 men each year (about 25,000 now) from slow, painful deaths from prostate cancer. And they are telling us to stop doing this test? Consider: 50,000 prostatectomies are performed each year for prostate cancer, yet 40,000 of these surgeries are unnecessary. The numbers are similar for radiation therapy. This is why mainstream medicine has retreated from routine PSA testing. Retreating

5 Ways to Prevent Unnecessary Treatment for Prostate Cancer Read More »

Prostate cancer now detectable using imaging-guided biopsy

Diagnosis / By / / 1 minute of reading

Groundbreaking research by a team of UCLA physicians and engineers demonstrates that prostate cancer — long identifiable only through painful, hit-or-miss biopsies — can be diagnosed far more easily and accurately using a new image-guided, targeted biopsy procedure. Read the article, which includes a video.

Prostate cancer now detectable using imaging-guided biopsy Read More »

New prostate cancer test could change treatment.

Diagnosis / By / / 1 minute of reading

Schulich School of Medicine & Dentistry professor Hon Leong has developed a new blood test which could detect the potential for prostate cancer earlier. Thousands of men face a prostate biopsy following higher-than-normal results from their annual prostate-specific antigen (PSA) test, the traditional screening for prostate cancer. But recent studies have shown three in four of these biopsies were unnecessary, leading to 165,000 unnecessary procedures and 6,930 related hospitalizations each year. Read more at: http://medicalxpress.com/news/2013-02-prostate-cancer-treatment.html#jCp

New prostate cancer test could change treatment. Read More »

PSA Levels Higher in Sedentary Men

Diagnosis, Exercise / By / / 1 minute of reading

PSA concentrations are higher in men who engage in more sedentary behavior and lower levels of light physical activity, a study found. It is hypothesized that regular participation in physical activity may reduce prostate cancer risk through a variety of biological mechanisms including changes in energy balance, immune function, inflammation, antioxidant defenses, and endogenous hormones. Based on their results, the authors stated, evaluation of a patient’s physical activity and sedentary level before PSA testing also is important because these factors also may influence measurements and lead to a urologic diagnostic workup. Read the whole article.

PSA Levels Higher in Sedentary Men Read More »

Scroll to Top